Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

151
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
151
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

128
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
128
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

124
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

224
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
224
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

7.2K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.2K
Fetal Circulation01:14

Fetal Circulation

2.0K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early risk stratification of late-onset sepsis in very preterm infants by intestinal microbiota profiling: a multicenter case-control validation study.

Gut microbes·2026
Same author

EBNEO Commentary: Expectant Management Versus Medication for Patent Ductus Arteriosus in Preterm Infants-The PDA RCT.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Neonatal sepsis and cardiovascular dysfunction II: assessment.

Pediatric research·2026
Same author

Lifestyle behaviours in children born extremely preterm at 2 years: a comparison to a Dutch reference population.

European journal of pediatrics·2026
Same author

Making sense of the evidence: designing randomised controlled trials for preterm infants with high-shunt volume patent ductus arteriosus.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Presepsin to safely reduce antibiotics in preterm infants (PRESAFE): study protocol for a randomized controlled trial with a concurrent observational study.

Trials·2026

Related Experiment Video

Updated: Dec 3, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.3K

Individualized Hemodynamic Management in Newborns.

Willem P de Boode1

  • 1Division of Neonatology, Department of Pediatrics, Radboud University Medical Center, Radboud Institute for Health Sciences, Amalia Children's Hospital, Nijmegen, Netherlands.

Frontiers in Pediatrics
|October 29, 2020
PubMed
Summary
This summary is machine-generated.

This review shifts from generalized protocols to individualized hemodynamic management for neonates. Tailoring treatment to each infant

Keywords:
hemodynamicshypotensionindividualized medicineneonatologypatent ductus arteriosispersistent pulmonary hypertension in the newborn (PPHN)shock

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.1K
Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.4K

Related Experiment Videos

Last Updated: Dec 3, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.3K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.1K
Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.4K

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Critical Care

Background:

  • Traditional "one-size-fits-all" protocols for neonatal hemodynamic management may not optimize patient outcomes.
  • Individual patient factors, including cardiovascular (patho-)physiology, are crucial for effective treatment.

Purpose of the Study:

  • To provide an overview of an individualized approach to neonatal hemodynamic management.
  • To highlight the transition from protocolized care to tailored interventions.
  • To discuss various neonatal hemodynamic conditions amenable to individualized management.

Main Methods:

  • This study is a narrative review.
  • It synthesizes current understanding and approaches in individualized neonatal hemodynamics.
  • Focuses on adapting management to patient-specific characteristics.

Main Results:

  • Individualized hemodynamic management, tailored to patient-specific cardiovascular (patho-)physiology and clinical status, is proposed as an improvement over generalized protocols.
  • This approach allows for more precise and effective interventions in various neonatal hemodynamic conditions.

Conclusions:

  • Transitioning to individualized hemodynamic management is key to improving patient outcomes in neonatology.
  • Tailoring interventions based on individual patient profiles is essential for addressing diverse neonatal hemodynamic challenges.